FDA Sent These Warning Letters To Pharma/Device Companies.
July 16, 2019 / BARBARA W. UNGER
There were six warning letter postings during this week: three drug warning letters including one regarding Akorn’s site in Somerset, NJ that the company announced a few weeks ago, one to a device manufacturer, one to an IRB, and one to a compounding pharmacy.